Brighton Center for Specialty Care

Brighton, Michigan 48116

0 studies enrolling now · 4 studies all time

What they study most

Colorectal Cancer, Esophageal Cancer, Gastric Cancer, Gastrointestinal Cancer, HER2-positive Breast Cancer, Lupus Nephritis, Non-Small-Cell Lung, Pancreatic Cancer, Stomach Cancer

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) — Completed
• An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis — Stopped early
• Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy — Completed